JSMVX | RPMGX | JSMVX / RPMGX | |
Total Expense Ratio | 1.23 | 0.75 | 164% |
Annual Report Gross Expense Ratio | 1.26 | 0.75 | 168% |
Fund Existence | 9 years | 33 years | - |
Gain YTD | 2.264 | 2.537 | 89% |
Front Load | N/A | N/A | - |
Min. Initial Investment | 2500 | 2500 | 100% |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 71M | 26.7B | 0% |
Annual Yield % from dividends | 0.00 | 0.00 | - |
Returns for 1 year | 4.16 | -5.53 | -75% |
Returns for 3 years | 23.71 | 19.23 | 123% |
Returns for 5 years | -41.69 | -4.29 | 971% |
Returns for 10 years | N/A | 28.82 | - |
1 Day | |||
---|---|---|---|
ETFs / NAME | Price $ | Chg $ | Chg % |
BBP | 72.16 | 0.53 | +0.75% |
Virtus LifeSci Biotech Products ETF | |||
JCPB | 47.45 | 0.04 | +0.08% |
JPMorgan Core Plus Bond ETF | |||
KCE | 151.18 | 0.10 | +0.07% |
SPDR® S&P Capital Markets ETF | |||
IBDZ | 26.44 | -0.01 | -0.04% |
iShares iBonds Dec 2034 Term Corp ETF | |||
SCJ | 90.90 | -0.53 | -0.58% |
iShares MSCI Japan Small-Cap ETF |